Literature DB >> 19116140

EGF promotes invasion by PANC-1 cells through Rac1/ROS-dependent secretion and activation of MMP-2.

Marcelo G Binker1, Andres A Binker-Cosen, Daniel Richards, Brenda Oliver, Laura I Cosen-Binker.   

Abstract

Cancer metastasis involves tumor cells invading the surrounding tissue. Remodeling of tissue barriers depends on the ability of tumor cells to degrade the surrounding collagen matrix and then migrate through the matrix defects. Epidermal growth factor (EGF) has been shown to regulate tumor cell invasion through activation of matrix metalloproteinase-2 (MMP-2) in various tumor cell types. In the present study, we investigated the role of MMP-2 and the signaling pathway involved in EGF-promoted invasion by human pancreatic cancer cells PANC-1. Using specific inhibitors, we found that EGF stimulation of these tumor cells induced secretion and activation of the collagenase MMP-2, which was required for EGF-stimulated basement membrane degradation and cell invasion. Our results also indicate that signaling events downstream of EGF receptor involved PI3K- and Src-dependent activation of Rac1, which mediated the NADPH-generated reactive oxygen species responsible for MMP-2 secretion and activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116140     DOI: 10.1016/j.bbrc.2008.12.080

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Antioxidant dieckol downregulates the Rac1/ROS signaling pathway and inhibits Wiskott-Aldrich syndrome protein (WASP)-family verprolin-homologous protein 2 (WAVE2)-mediated invasive migration of B16 mouse melanoma cells.

Authors:  Sun Joo Park; Yong Tae Kim; You Jin Jeon
Journal:  Mol Cells       Date:  2012-03-21       Impact factor: 5.034

2.  Rac1-mediated mitochondrial H2O2 generation regulates MMP-9 gene expression in macrophages via inhibition of SP-1 and AP-1.

Authors:  Shubha Murthy; Alan Ryan; Chao He; Rama K Mallampalli; A Brent Carter
Journal:  J Biol Chem       Date:  2010-06-07       Impact factor: 5.157

3.  NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2α.

Authors:  Jennifer L Gregg; Robert M Turner; Guimin Chang; Disha Joshi; Ye Zhan; Li Chen; Jodi K Maranchie
Journal:  Cancer Res       Date:  2014-04-22       Impact factor: 12.701

Review 4.  Enhancing the efficacy of mesenchymal stem cell therapy.

Authors:  Michalis Mastri; Huey Lin; Techung Lee
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 5.  Redox signaling at invasive microdomains in cancer cells.

Authors:  Begoña Díaz; Sara A Courtneidge
Journal:  Free Radic Biol Med       Date:  2011-09-29       Impact factor: 7.376

6.  Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.

Authors:  Zhimin Tong; Subhankar Chakraborty; Bokyung Sung; Pooja Koolwal; Sukhwinder Kaur; Bharat B Aggarwal; Sendurai A Mani; Robert S Bresalier; Surinder K Batra; Sushovan Guha
Journal:  Cancer       Date:  2010-12-29       Impact factor: 6.860

7.  Reactive oxygen species and tumor metastasis.

Authors:  Doo Jae Lee; Sang Won Kang
Journal:  Mol Cells       Date:  2013-02-21       Impact factor: 5.034

Review 8.  Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.

Authors:  Zhiwei Wang; Yiwei Li; Fazlul H Sarkar
Journal:  Curr Stem Cell Res Ther       Date:  2010-03       Impact factor: 3.828

9.  Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells.

Authors:  Xiang Wu; Yu Zhu; Huiqin Yan; Boning Liu; Ying Li; Qinghua Zhou; Ke Xu
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

Review 10.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.